drugset / Trial / NCT07051031
COVID-19 Reactogenicity
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to compare post-vaccination reactions between the protein-based Novavax vaccine and the mNEXSPIKE mRNA-1283 vaccine. Specifically, the study aims to determine the rate of participant-reported symptoms associated with each type of vaccine.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2026-06-14
- Completion
- 2026-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nuvaxovid | Vaccine | — | — |
| Subject | mNEXSPIKE | Messenger RNA (mRNA) | — | — |